Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology ; day:26 ; month:11 ; year:2021 ; extent:13
The EMBO journal / European Molecular Biology Organization ; (26.11.2021) (gesamt 13)
- Urheber
-
Kummer, Markus P.
Ising, Christina
Kummer, Christiane
Sarlus, Heela
Griep, Angelika
Vieira‐Saecker, Ana
Schwartz, Stephanie
Halle, Annett
Brückner, Matthias
Händler, Kristian
Schultze, Joachim L.
Beyer, Marc
Latz, Eicke
Heneka, Michael T.
- DOI
-
10.15252/embj.2021108662
- URN
-
urn:nbn:de:101:1-2021112614275780117626
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kummer, Markus P.
- Ising, Christina
- Kummer, Christiane
- Sarlus, Heela
- Griep, Angelika
- Vieira‐Saecker, Ana
- Schwartz, Stephanie
- Halle, Annett
- Brückner, Matthias
- Händler, Kristian
- Schultze, Joachim L.
- Beyer, Marc
- Latz, Eicke
- Heneka, Michael T.
Ähnliche Objekte (12)
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Microglial Activation in Alzheimer’s Disease
A change of PD-1/PD-L1 expression on peripheral T cell subsets correlates with the different stages of Alzheimer's Disease
Regulatory mechanisms of PD-1/PD-L1 in cancers
PD-1/PD-L1 binding studies using microscale thermophoresis
The PD-1:PD-L1 axis in Inflammatory Arthritis
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Microglial Activation in Alzheimer’s Disease
A change of PD-1/PD-L1 expression on peripheral T cell subsets correlates with the different stages of Alzheimer's Disease
Regulatory mechanisms of PD-1/PD-L1 in cancers
PD-1/PD-L1 binding studies using microscale thermophoresis
The PD-1:PD-L1 axis in Inflammatory Arthritis
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer’s disease
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Microglial Activation in Alzheimer’s Disease
A change of PD-1/PD-L1 expression on peripheral T cell subsets correlates with the different stages of Alzheimer's Disease
Regulatory mechanisms of PD-1/PD-L1 in cancers
PD-1/PD-L1 binding studies using microscale thermophoresis
The PD-1:PD-L1 axis in Inflammatory Arthritis
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?